MASECO Private Wealth’s West Pharmaceutical WST Stock Holding History

MASECO Private Wealth’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9	Closed	-$1.97K	–	531
2025 Q2	$1.97K	Buy	+9	New	+$1.92K	﹤0.01%	457

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

MASECO Private Wealth's WST Position: Q3 2025 in Review

MASECO Private Wealth sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 9 shares — an estimated $1.97K sold.

MASECO Private Wealth first reported a position in WST in Q2 2025 and held it in 1 quarter. The position peaked at $1.97K in Q2 2025. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

MASECO Private Wealth reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
MASECO Private Wealth sold 9 West Pharmaceutical shares in Q3 2025, an estimated $1.97K.
MASECO Private Wealth first reported a position in West Pharmaceutical in Q2 2025 and held it in 1 quarter.
MASECO Private Wealth's West Pharmaceutical position peaked at $1.97K in Q2 2025.
758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on MASECO Private Wealth's 13F filing for Q3 2025, filed 12 Nov 2025.